Table 1.
Distribution of low and high SRAP cases in case subgroups
| Case subgroups | Low SRAP | High SRAP | Total | P value |
|---|---|---|---|---|
| n (%) | n (%) | |||
| ER - | 72 (71) | 29 (29) | 101 | < 0.0001 |
| ER+ | 115 (42) | 156 (58) | 271 | |
| PR - | 78 (67) | 37 (33) | 115 | 0.0053 |
| PR+ | 112(44) | 145 (56) | 257 | |
| Node - | 95 (55) | 80 (45) | 172 | 0.2545 |
| Node + | 95 (48) | 102 (52) | 200 | |
| Low (3-5) | 30 (39) | 47 (61) | 77 | < 0.0001 |
| Med (6-7) | 97 (47) | 109 (53) | 206 | |
| High (8-9) | 63 (71) | 26 (29) | 89 | |
| Low size (≤ 2.5 cm) | 105 (54) | 90 (46) | 195 | 0.2992 |
| High size (> 2.5 cm) | 85 (48) | 92 (52) | 177 | |
| Age ≤ 64 | 113 (60) | 77 (40) | 190 | 0.0013 |
| Age > 64 | 77 (42) | 105 (58) | 182 | |
| Total | 190 | 182 | 372 | |
P-values correspond to Fisher's exact test. ER = estrogen receptor; PR = progesterone receptor; SRAP = steroid receptor RNA activator protein; + = positive; - = negative.